Tretinoin 0.01% Ophthalmic Solution

Tretinoin 0.01% Ophthalmic Solution is for topical ophthalmic use and is commonly used to treat corneal keratinization and severe dry eye disorders.

• Volume: 5ml
• Concentration: 0.01%
• We exclusively compound Tretinoin 0.01% Ophthalmic Solution for ophthalmic use only
• Compounded in a sterile compounding facility that is <795>, <797> and <800> chapter compliant

1. Soong HK, Martin NF, Wagoner MD, et al. Topical retinoid therapy for squamous metaplasia of ocular surface disorders: a multicenter, placebo-controlled study. Ophthalmology. 1988;95(10):1442-1446. PMID: 3050697. https://pubmed.ncbi.nlm.nih.gov/3050697/
2. Tseng SCG. Topical tretinoin treatment for severe dry-eye disorders. J Am Acad Dermatol. 1986;15(4 Pt 2):860-866. PMID: 3534078. https://pubmed.ncbi.nlm.nih.gov/3534078/
3. Pflugfelder SC, de Paiva CS. The pathophysiology of dry eye disease. Ocul Surf. 2017;15(3):438-510. PMID: 28427931. https://pubmed.ncbi.nlm.nih.gov/28427931/